The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China

The pandemic outbreak of coronavirus disease 2019 (COVID-19) is rapidly spreading all over the world. Reports from China showed that about 20% of patients developed severe disease, resulting in a fatality of 4%. In the past two months, we clinical immunologists participated in multi-rounds of MDT (m...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wen, Zhao, Yan, Zhang, Fengchun, Wang, Qian, Li, Taisheng, Liu, Zhengyin, Wang, Jinglan, Qin, Yan, Zhang, Xuan, Yan, Xiaowei, Zeng, Xiaofeng, Zhang, Shuyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102614/
https://www.ncbi.nlm.nih.gov/pubmed/32222466
http://dx.doi.org/10.1016/j.clim.2020.108393

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102614/
https://www.ncbi.nlm.nih.gov/pubmed/32222466
http://dx.doi.org/10.1016/j.clim.2020.108393

Ejemplares similares